Retatrutide 20mg
Triple-Agonist Peptide for Metabolic & Endocrine Pathway Research
🎁 FREE 3ml Bacteriostatic Water with Every Vial Purchased
Every peptide vial order automatically includes a complimentary 3ml vial of bacteriostatic water at no extra cost.
$150.00
- 99%+ Purity Tested
- Canadian Lab Tested
- Ships from Toronto, Ontario
- Free Bacteriostatic Water with Every Order
Overview
Retatrutide is a synthetic peptide studied for its activity across three metabolic hormone receptor pathways:
- Glucagon-like peptide-1 (GLP-1)
- Glucose-dependent insulinotropic polypeptide (GIP)
- Glucagon (GCGR)
In research settings, Retatrutide is examined as a multi-receptor signaling model for investigating metabolic regulation, energy balance, and endocrine system coordination.
Due to its triple-agonist profile, Retatrutide is frequently referenced in metabolic, obesity, energy expenditure, and endocrine signaling research models, where pathway interaction and signal integration are of interest.
Mechanism of Action
Retatrutide is designed to interact with multiple metabolic hormone receptors, allowing researchers to study coordinated signaling across distinct but interrelated endocrine pathways.
Research indicates Retatrutide engages:
- GLP-1 receptors, involved in appetite regulation and glucose signaling
- GIP receptors, associated with nutrient-dependent endocrine responses
- Glucagon receptors, linked to energy expenditure and metabolic output
This multi-agonist design enables investigation of synergistic and counter-regulatory signaling, making Retatrutide a valuable tool for studying complex metabolic networks rather than isolated pathways.
Research Applications
Metabolic Regulation Research
Retatrutide is widely studied in metabolic signaling models:
- Energy balance pathway analysis
- Metabolic rate and substrate utilization signaling
- Hormonal coordination of nutrient intake and output
- Integrated metabolic response studies
Glucose & Endocrine Signaling Research
Triple-agonist activity makes Retatrutide relevant for:
- Glucose homeostasis pathway modeling
- Hormonal cross-talk studies
- Endocrine feedback loop analysis
- Multi-receptor signaling dynamics
Appetite & Energy Balance Research
Retatrutide is examined in appetite-related research contexts:
- Central and peripheral appetite signaling
- Satiety pathway interaction
- Energy intake regulation models
- Neuroendocrine control of feeding behavior
Obesity & Body Composition Research
Complex metabolic signaling is central to body composition studies:
- Adipose tissue signaling pathways
- Lipid metabolism regulation
- Energy expenditure vs. storage modeling
- Weight-regulation signaling research
Cardiometabolic Research
Metabolic hormones influence cardiovascular systems:
- Cardiometabolic signaling pathways
- Lipid and glucose interaction studies
- Systemic metabolic stress models
- Endocrine contributions to cardiometabolic balance
Research Advantages
Why Researchers Study Retatrutide
- Triple-agonist activity in a single peptide
- Enables study of integrated metabolic signaling
- Useful for pathway interaction and synergy research
- Relevant across glucose, appetite, and energy systems
- Frequently referenced in next-generation metabolic studies
Retatrutide is valued for its systems-level metabolic signaling profile, rather than single-pathway stimulation.
IMPORTANT:
This product is exclusively intended for laboratory research purposes only.
Not approved for human consumption or veterinary use.
Not intended for diagnostic, therapeutic, or consumable applications.
Scientific References
Coskun T, et al. “Triple-agonist peptides for the treatment of metabolic disease.” Cell Metabolism. 2022.
Campbell JE, Drucker DJ. “Pharmacology, physiology, and mechanisms of incretin hormone action.” Cell Metab. 2013.
Holst JJ, et al. “GLP-1, GIP, and glucagon signaling in metabolic regulation.” Nat Rev Endocrinol. 2018.
Finan B, et al. “Unimolecular multi-agonists for metabolic disease.” Trends Endocrinol Metab.